Business Wire

KOKUYO to Showcase the Revolutionary "360° Gliding Chair ing" at ORGATEC 2018

Share

KOKUYO Co., Ltd. (TOKYO: 7984), a leading provider of office design and furniture in Japan, will take part in ORGATEC 2018 (http://www.orgatec.com/). The exhibition, held in Cologne, Germany, from October 23rd to 27th, is the largest International Trade Fair for Furnishing and Management of Offices and Office Facilities. This year, KOKUYO will present its revolutionary office chair, “360° Gliding Chair ing”, which is never seen before in Europe.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181016005530/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

The "360° Gliding Chair ing" defines the way you sit. (Photo: Business Wire)

“360° Gliding Chair ing” is an office chair with a completely new concept to improve white-collar health and creativity. Nowadays, research confirmed that sitting for long hours not only causes white-collar workers' discomfort but also serious health issues. To address this problem, KOKUYO pioneered the innovative chair, “360° Gliding Chair ing”, which keeps a correct sitting posture by its 360° freely moving.

- “360° Gliding Chair ing” web : https://www.kokuyo-furniture.com/portfolio-item/ing-2/
- Concept video: https://youtu.be/pQutBSTzv9A

At the beginning, KOKUYO has released it to Japanese market in November 2017. After an overwhelming successful response from white-collar workers in Japan, the “360° Gliding Chair ing” is now ready to be introduced in Europe and other regions.

Through this exhibition, KOKUYO would like everyone to experience the state-of-the-art functionalities and innovative concept of “360° Gliding Chair ing”. Moreover, KOKUYO hopes that this will catapult the growth of the business in the world-wide market.

The feature of “360° Gliding Chair ing”

The innovative “360° Gliding Chair ing” mimics the hip-strengthening action of sitting on a balance ball. Its 360° freely moving joints move according to the fine movement of the human body. To balance chair’s movement, the body naturally and perfectly maintain a correct sitting posture. This freedom of movement keeps the hips, waist and back muscles active while seated. Body pressure is also dispersed with the movement, reducing strain on the body.

Exhibition Overview

Exhibition Special page: https://www.kokuyo-furniture.com/kokuyo_ing/
Exhibition theme: “360° Gliding”
Booth: B-050, Hall 7.1
Period: Oct 23 (Tue) - 27 (Sat), 2018 / 9:00-18:00 (Saturday until 16:00)
Venue: Koelnmesse
Address: Messeplatz 1, 50679 Cologne, Germany

[Related Links]
KOKUYO’s Official web : https://www.kokuyo-furniture.com/

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

[Media Contact]
KOKUYO
Kelvin WU, +65 6222 9762
kelvin@kokuyo.com
Media Relations

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 15:30:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 15:00:00 EEST | Press release

The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin

IonQ Unanimously Appoints Peter Chapman as Next Chairman of the Board of Directors26.4.2024 14:30:00 EEST | Press release

IonQ (NYSE: IONQ), a leader in the quantum computing industry, announced today the appointment of Peter Chapman as its next Chairman of the Board and Harry You as the Lead Independent Director of the Board, effective at the close of IonQ’s upcoming Annual General Meeting on June 5, 2024. Both appointments were disclosed in a proxy statement issued on April 25, 2024. Peter Chapman has also been nominated for re-election as a Class III director at the meeting, and his chairmanship will take effect assuming he is re-elected. “Last quarter we were delighted to have appointed Robert Cardillo and Bill Scannell to our Board of Directors. In addition, the Board unanimously appointed Peter Chapman to serve as its next Chairman following the annual meeting given his half-decade worth of contributions to IonQ and his strong progress transitioning IonQ from an academic to a commercial company,” said Niccolo de Masi, Chairman of the Nominating & Corporate Governance Committee of IonQ’s Board. “Unde

Sealing System launches: XIO – Intelligent Farming26.4.2024 13:17:00 EEST | Press release

XIO – Intelligent Farming, specializes in logistics systems for insect protein production. XIO is a new business unit within Sealing System A/S, one of the leading providers of automated end-of-line packaging lines in Scandinavia. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240426832303/en/ Robotic solution handling Black Soldier Fly Larvae (Photo: Business Wire) “At Sealing System A/S, we believe that practical innovation is the engine of real-world change. With the establishment of, XIO - Intelligent Farming, we are setting new industry standards, emphasizing the importance of intralogistics in the field of insect protein production, and proudly leading the way.” Ole Jensen CEO, Sealing System A/S XIO – Intelligent Farming provides solutions serving various aspects of the insect production, including fully automatic logistics systems, comprehensive data tracking, transfer trolleys and shuttles, as well as robot systems

Tecnotree Achieves Strong Q1 2024 Results with Sustained Revenue Growth and Enhanced Profitability26.4.2024 11:46:00 EEST | Press release

Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, today announced its financial results for the first quarter of 2024, demonstrating solid growth with a 4.7% increase in revenue. The company maintained its momentum in driving global sales of its digital platform, in the first quarter of 2024, completing many AIML and digital transformations to key customers, resulting in a significant increase in revenue. The growth was primarily driven by new wins in the LATAM region, while EMEA and APAC regions remain growing markets for the digital platform. Key Q1 Highlights of the financial results: Net sales increased 4.7% to EUR 16.3 (15.5) million. Operating results increased by 22.3% to EUR 4.4 (3.6) million. Earnings per share EUR 0.01 (0.01). Order book at the end of the period increased by 10.3% to EUR 74.8 (67.8) million. Tecnotree achieved several notable milestones in the first quarter. The company solidified its position as a trusted par

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye